TAG
PRNewswire
InxMed Releases Data Demonstrating Ifebemtinib (IN10018) Trending Toward Survival Benefit at ESMO 2023
Clinical data of IN10018, a drug for solid tumors, presented at ESMO Congress.
James M. Kondo Joins US-Japan Foundation Board
James M. Kondo joins the board of Trustees for the United States-Japan Foundation.
2023 Business and Philanthropy Forum by Alliance For Good: Catalysing Next-Gen Leaders to Drive Change
Singapore's Alliance For Good partners with NTU and Asia Family Office Association to host Business and Philanthropy Forum 2023 on November 9-10. The forum aims to align wealth with purpose, address global challenges, and promote value-based investment. The program includes keynote speeches and breakout sessions on strategic philanthropy, sustainable investment, and the future of finance. Distinguished speakers include leaders from various industries and previous editions featured notable figures like Howard Warren Buffett and Maya Soetoro-Ng. The Alliance For Good is a philanthropy network based in Singapore, known for organizing large-scale events.
Sendbird Expands Customer Choices through Integration of Meta's Llama2
Sendbird integrates Meta's Llama2 into its communication platform, offering AI chatbot capabilities.
CNOOC Limited Discovers Deep Coalbed Methane Field with Proved Gas In-place of over 100 Billion Cubic Meters
CNOOC discovers Shenfu deep CBM field in China, adding over 100 billion cubic meters of gas in-place.
Inmotive Receives Strategic Investment from Suzuki
Suzuki invests in Inmotive to support development of 2-speed EV transmission.
Cancer Prevention Scholars and Climate Crisis Experts from Korea, US and Japan Come Together, iCOOP KOREA Holds the '2023 International Symposium'
iCOOP KOREA held a symposium on cancer prevention and climate crisis. Experts discussed challenges and cooperation.
Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO
Glecirasib and JAB-3312 combination therapy showed positive efficacy signals in NSCLC.
